GGrantIndex
← Leaderboards

Gonzague Joseph Jourdain

Institute Of Research And Development

$6,475,740
Attributed
$6,475,740
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY201122
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,475,740 · 5

By mechanism

UM1$2,204,287 · 1
R01$2,183,868 · 1
U01$1,980,751 · 2
R03$106,834 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Vertical Disease Transmission

Research focus

Vertical Disease TransmissionAdultThailandPreventSiteGuidelinesChronicSafetyTenofovirPreventionChronic Hepatitis BHepatitis BInfantHepatitis B TransmissionRandomizedHepatitis B VirusPostpartum PeriodMothersImmunoglobulinsPregnant WomenEnrollmentDouble-Blind MethodPlacebosPregnancy

Grant awards (17)

Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$409,167
R01 · FY2022 · HD · contact PI
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$433,628
R01 · FY2021 · HD · contact PI
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$442,553
R01 · FY2020 · HD · contact PI
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$445,447
R01 · FY2019 · HD · contact PI
Kidney Tubular Dysfunction in Hepatitis B Mono-Infected Women Receiving a Short Tenofovir Disoproxil Fumarate Course in Pregnancy and Postpartum Period to Prevent Mother to Child Transmission$53,104
R03 · FY2019 · HD · contact PI
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$453,073
R01 · FY2018 · HD · contact PI
Kidney Tubular Dysfunction in Hepatitis B Mono-Infected Women Receiving a Short Tenofovir Disoproxil Fumarate Course in Pregnancy and Postpartum Period to Prevent Mother to Child Transmission$53,730
R03 · FY2018 · HD · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$100,000
U01 · FY2016 · HD · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$294,395
U01 · FY2015 · HD · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$188,154
U01 · FY2015 · HD · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$479,336
U01 · FY2014 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$204,935
UM1 · FY2014 · AI · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$865,026
UM1 · FY2013 · AI · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$457,666
U01 · FY2013 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,134,326
UM1 · FY2012 · AI · contact PI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$461,199
U01 · FY2012 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1
U01 · FY2011 · AI · contact PI